Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

EpiDisease SL

SME

www.epidisease.comValencia, Spain
1 profile visit

About

At EpiDisease SL, we focus on advancing public health through innovative digital solutions and epidemiological research. Our team is dedicated to providing cutting-edge tools and insights that help organizations understand and combat disease outbreaks effectively. By leveraging data analytics and technology, we empower stakeholders to make informed decisions that enhance community health outcomes. We are committed to fostering collaboration and sharing knowledge to navigate the challenges of global health together.

Social media

What is your business/industry sector?

Biotech, Pharma and CosmeticsHealthcareOther

Representatives

James Webb

Chief Commercial Officer

EpiDisease SL

Marketplace (2)

  • Partnership

    HIST — HistSHOCK & HistSHOCK CDx

    First histone-based IVD test to diagnose sepsis (Sn77%, Sp89%) & predict septic shock. 450-patient RWE trial finsished 1Q26. CE-IVD Q1 2027. CDx for Phase II anti-histone therapy on-going. $16B+ SAM. Seeking pharma co-development & out-licensing partners.

    Author

    James Webb

    Chief Commercial Officer at EpiDisease SL

    Valencia, Spain